Click here to learn about Academy events, publications and initiatives around COVID-19.

We are experiencing intermittent technical difficulties. At this time, you may not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

Support The World's Smartest Network
×

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

DONATE
This site uses cookies.
Learn more.

×

This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.

Immune Contribution to Heart Failure and Therapeutic Opportunities

Immune Contribution to Heart Failure and Therapeutic Opportunities

Tuesday, October 27, 2020, 8:30 AM - 6:00 PM EDT

The New York Academy of Sciences
7 World Trade Center, New York City, USA

Presented By

The Biochemical Pharmacology Discussion Group

The New York Academy of Sciences

 

Despite recent advances in treatment options, and trending improvements in survival over the last several decades, therapeutic interventions for heart failure largely fail to resolve the underlying disease. Understanding the pathophysiological role of inflammatory cells in response to myocardial damage presents a new area of therapeutic opportunity. This symposium will focus on novel immunological mechanisms that contribute to the onset and progression of heart failure, and discussions will include the post-myocardial infarct immune system, hypertension-induced cardiac inflammation, macrophages and their role in ischemic and non-ischemic heart failure, and the anti-inflammatory hypothesis. A special focus will be given to the current state of small molecule and biologic therapies targeting the immune system for this disease.

Call for Abstracts

Abstract submissions are invited for a poster session. For complete submission instructions, please visit our online portal. The deadline for abstract submission is Tuesday, August 18, 2020.

Registration

Member
By 09/15/2020
$90
After 09/15/2020
$130
Nonmember Academia, Faculty, etc.
By 09/15/2020
$180
After 09/15/2020
$260
Nonmember Corporate, Other
By 09/15/2020
$250
After 09/15/2020
$350
Nonmember Not for Profit
By 09/15/2020
$180
After 09/15/2020
$260
Nonmember Student, Undergrad, Grad, Fellow
By 09/15/2020
$100
After 09/15/2020
$145
Member Student, Post-Doc, Fellow
By 09/15/2020
$50
After 09/15/2020
$70
Earlybird Registration:
113
days
left
Deadline:
85
days
left

Scientific Organizing Committee

Michael Dunn, PhD

Regeneron

DeLisa Fairweather, PhD, FAHA

Mayo Clinic

Nikolaos G. Frangogiannis, MD

Albert Einstein College of Medicine

Scott MacDonnell, PhD

Regeneron

Akshay Shekhar, PhD

Regeneron

Filip K. Swirski, PhD

Harvard Medical School; Massachusetts General Hospital 

Sonya Dougal, PhD

New York Academy of Sciences

Kari Fischer, PhD

New York Academy of Sciences

Keynote Speaker

Douglas L. Mann, MD

Washington University School of Medicine

Speakers

Pilar Alcaide, PhD

Tufts University

Bryce Binstadt, MD, PhD

University of Minnesota

Jonathan Epstein, MD

University of Pennsylvania

DeLisa Fairweather, PhD, FAHA

Mayo Clinic

Joan Heller Brown, PhD

University of California, San Diego

Siddartha Jaiswal, MD, PhD

Stanford University

Kory J. Lavine, MD, PhD

Washington University School of Medicine

Na Li, PhD

Baylor College of Medicine

Program Supporters